Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite

Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite

Source: 
Motley Fool
snippet: 
  • Abbott's most important franchise works well in combination with weight-loss treatments.
  • The company is also looking to address another problem these medicines create.
  • There are many reasons to invest in Abbott, including its innovative qualities and the dividend.